No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
ENTA250117P12500
- 2.30
- 0.000.00%
15min DelayClose Dec 24 13:00 ET
0.00High0.00Low
2.30Open2.30Pre Close0 Volume12 Open Interest12.50Strike Price0.00Turnover380.80%IV-67.21%PremiumJan 17, 2025Expiry Date6.40Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.5962Delta0.0652Gamma0.82Leverage Ratio-0.0473Theta-0.0059Rho-0.49Eff Leverage0.0061Vega
Intraday
- 5D
- Daily
News
Sector Update: Health Care Stocks Mixed Tuesday Afternoon
Top Midday Decliners
CrowdStrike To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
Enanta Pharmaceuticals to Appeal Court Ruling on Patent Infringement Case Against Pfizer
Enanta Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
H.C. Wainwright Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Cuts Target Price to $18